Control of Medulloblastoma Migration & Survival by Unc5c
控制髓母细胞瘤迁移
基本信息
- 批准号:8269524
- 负责人:
- 金额:$ 4.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-06-01 至 2011-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Medulloblastoma is the most common malignant brain tumor in children. Its rapid growth and tendency to spread through the nervous system make it extremely difficult to treat, and more than 40% of the children who develop the disease die from it. Improved treatment of medulloblastoma is likely to come from a deeper understanding of the signals that control normal cerebellar development, and an appreciation of how these signals are dysregulated in tumors. To identify such signals, we have studied an animal model of medulloblastoma - the patched mutant mouse - and identified genes whose expression is altered in tumor cells compared to granule cell precursors (GCPs), the cells from which the tumor is believed to arise. Among the genes whose expression decreased most significantly was Unc5c, which encodes a receptor for the netrin family of signaling molecules. Unc5c was originally described as a regulator of cell migration, but has recently been shown to play an important role in apoptosis as well. Moreover, Unc5c is deleted or mutated in a variety of cancers, and has therefore been suggested to function as a tumor suppressor. We hypothesize that Unc5c controls migration and survival of GCPs during normal cerebellar development, and that its loss contributes to the abnormal migration and increased survival observed in medulloblastoma. If this hypothesis is correct, it will have important implications for our understanding of medulloblastoma, and open up new avenues for treatment of the disease. To test our hypothesis, we propose to: 1) Determine whether Unc5c regulates inward migration of granule cell precursors and tumor cells 2) Test whether Unc5c regulates survival of granule cell precursors and tumor cells 3) Determine whether loss of Unc5c is required for medulloblastoma formation Relevance to Public Health: One of the greatest challenges in medulloblastoma treatment is the ability of tumor cells to migrate into regions where they would not normally go, and to survive once they get there. Our observation of altered Unc5c expression in medulloblastoma is significant because it can contribute to both of these behaviors. By elucidating the role of Unc5c in migration and survival, our studies will shed light on the molecular mechanisms that underlie the aggressive growth and dissemination of medulloblastoma. This, in turn, will pave the way for developing new treatments that can be used to fight this devastating disease.
描述(由申请人提供):髓母细胞瘤是儿童中最常见的恶性脑肿瘤。神经管母细胞瘤是一种神经系统疾病,它的生长速度快,易于通过神经系统扩散,因此治疗非常困难,超过40%的儿童死于这种疾病。神经管母细胞瘤的治疗方法的改进可能来自于对控制正常小脑发育的信号的更深入的理解,以及对这些信号在肿瘤中是如何失调的理解。为了识别这些信号,我们研究了髓母细胞瘤的动物模型-补丁突变小鼠-并确定了与颗粒细胞前体(GCPs)相比,肿瘤细胞中表达发生改变的基因,肿瘤被认为是由颗粒细胞前体(GCPs)引起的。其中表达下降最显著的基因是Unc 5c,它编码netrin家族信号分子的受体。Unc 5c最初被描述为细胞迁移的调节剂,但最近已被证明在凋亡中也起重要作用。此外,Unc 5c在多种癌症中缺失或突变,因此被认为是肿瘤抑制因子。我们推测Unc 5c在正常小脑发育过程中控制着GCPs的迁移和存活,其缺失导致了在髓母细胞瘤中观察到的异常迁移和存活增加。如果这一假设是正确的,它将对我们理解髓母细胞瘤有重要意义,并为治疗该病开辟新的途径。为了验证我们的假设,我们建议:1)确定Unc 5c是否调节颗粒细胞前体细胞和肿瘤细胞的向内迁移2)测试Unc 5c是否调节颗粒细胞前体细胞和肿瘤细胞的存活3)确定Unc 5c的缺失是否是髓母细胞瘤形成所必需的。髓母细胞瘤治疗中最大的挑战之一是肿瘤细胞迁移到它们通常不会去的区域的能力,并且一旦它们到达那里就能够存活。我们在髓母细胞瘤中观察到Unc 5c表达的改变是有意义的,因为它可以促进这两种行为。通过阐明Unc 5c在迁移和生存中的作用,我们的研究将揭示髓母细胞瘤侵袭性生长和播散的分子机制。反过来,这将为开发可用于对抗这种毁灭性疾病的新疗法铺平道路。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma.
- DOI:10.1016/j.ccr.2008.12.016
- 发表时间:2009-02-03
- 期刊:
- 影响因子:50.3
- 作者:Read TA;Fogarty MP;Markant SL;McLendon RE;Wei Z;Ellison DW;Febbo PG;Wechsler-Reya RJ
- 通讯作者:Wechsler-Reya RJ
Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells.
- DOI:10.1016/j.ccr.2008.07.003
- 发表时间:2008-08-12
- 期刊:
- 影响因子:50.3
- 作者:Yang ZJ;Ellis T;Markant SL;Read TA;Kessler JD;Bourboulas M;Schüller U;Machold R;Fishell G;Rowitch DH;Wainwright BJ;Wechsler-Reya RJ
- 通讯作者:Wechsler-Reya RJ
Targeting sonic hedgehog-associated medulloblastoma through inhibition of Aurora and Polo-like kinases.
- DOI:10.1158/0008-5472.can-12-4258
- 发表时间:2013-10-15
- 期刊:
- 影响因子:11.2
- 作者:Markant SL;Esparza LA;Sun J;Barton KL;McCoig LM;Grant GA;Crawford JR;Levy ML;Northcott PA;Shih D;Remke M;Taylor MD;Wechsler-Reya RJ
- 通讯作者:Wechsler-Reya RJ
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert J. Wechsler-Reya其他文献
RETRACTED ARTICLE: Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastoma
撤回文章:肿瘤坏死因子克服 p53 突变型髓母细胞瘤中的免疫逃避
- DOI:
10.1038/s41593-020-0628-4 - 发表时间:
2020-05-18 - 期刊:
- 影响因子:20.000
- 作者:
Alexandra Garancher;Hiromichi Suzuki;Svasti Haricharan;Lianne Q. Chau;Meher Beigi Masihi;Jessica M. Rusert;Paula S. Norris;Florent Carrette;Megan M. Romero;Sorana A. Morrissy;Patryk Skowron;Florence M. G. Cavalli;Hamza Farooq;Vijay Ramaswamy;Steven J. M. Jones;Richard A. Moore;Andrew J. Mungall;Yussanne Ma;Nina Thiessen;Yisu Li;Alaide Morcavallo;Lin Qi;Mari Kogiso;Yuchen Du;Patricia Baxter;Jacob J. Henderson;John R. Crawford;Michael L. Levy;James M. Olson;Yoon-Jae Cho;Aniruddha J. Deshpande;Xiao-Nan Li;Louis Chesler;Marco A. Marra;Harald Wajant;Oren J. Becher;Linda M. Bradley;Carl F. Ware;Michael D. Taylor;Robert J. Wechsler-Reya - 通讯作者:
Robert J. Wechsler-Reya
Integrated genome and tissue engineering enables screening of cancer vulnerabilities in physiologically relevant perfusable emex vivo/em cultures
整合基因组和组织工程技术能够在生理相关的可灌注体外培养物中筛选癌症的脆弱性
- DOI:
10.1016/j.biomaterials.2021.121276 - 发表时间:
2022-01-01 - 期刊:
- 影响因子:12.900
- 作者:
Michael Hu;Xin Yi Lei;Jon D. Larson;Melissa McAlonis;Kyle Ford;Daniella McDonald;Krystal Mach;Jessica M. Rusert;Robert J. Wechsler-Reya;Prashant Mali - 通讯作者:
Prashant Mali
Single-cell mapping identifies MSIsup+/sup cells as a common origin for diverse subtypes of pancreatic cancer
单细胞图谱确定 MSI+/细胞是胰腺癌不同亚型的共同起源
- DOI:
10.1016/j.ccell.2023.09.008 - 发表时间:
2023-11-13 - 期刊:
- 影响因子:44.500
- 作者:
Nirakar Rajbhandari;Michael Hamilton;Cynthia M. Quintero;L. Paige Ferguson;Raymond Fox;Christian M. Schürch;Jun Wang;Mari Nakamura;Nikki K. Lytle;Matthew McDermott;Emily Diaz;Hannah Pettit;Marcie Kritzik;Haiyong Han;Derek Cridebring;Kwun Wah Wen;Susan Tsai;Michael G. Goggins;Andrew M. Lowy;Robert J. Wechsler-Reya;Tannishtha Reya - 通讯作者:
Tannishtha Reya
The transcription factor LHX2 mediates and enhances oncogenic BMP signaling in medulloblastoma
转录因子 LHX2 介导并增强髓母细胞瘤中的致癌性骨形态发生蛋白信号通路。
- DOI:
10.1038/s41418-025-01488-6 - 发表时间:
2025-03-28 - 期刊:
- 影响因子:15.400
- 作者:
Yae Ohata;Mohamad M. Ali;Yutaro Tsubakihara;Yuka Itoh;Gabriela Rosén;Tobias Bergström;Anita Morén;Irene Golán-Cancela;Ayana Nakada;Oleksandr Voytyuk;Maiko Tsuchiya;Rei Fukui;Kouhei Yamamoto;Paula Martín-Rubio;Patricia Sancho;Carina Strell;Patrick Micke;Robert J. Wechsler-Reya;Yoshinobu Hashizume;Kohei Miyazono;Laia Caja;Carl-Henrik Heldin;Fredrik J. Swartling;Aristidis Moustakas - 通讯作者:
Aristidis Moustakas
Robert J. Wechsler-Reya的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert J. Wechsler-Reya', 18)}}的其他基金
Identifying and Targeting the Drivers of Pediatric Brain Tumors
识别并针对儿童脑肿瘤的驱动因素
- 批准号:
10708545 - 财政年份:2022
- 资助金额:
$ 4.78万 - 项目类别:
Identifying and Targeting the Drivers of Pediatric Brain Tumors
识别并针对儿童脑肿瘤的驱动因素
- 批准号:
10397691 - 财政年份:2021
- 资助金额:
$ 4.78万 - 项目类别:
Identifying and Targeting the Drivers of Pediatric Brain Tumors
识别并针对儿童脑肿瘤的驱动因素
- 批准号:
10240154 - 财政年份:2021
- 资助金额:
$ 4.78万 - 项目类别:
Regulation of Medulloblastoma Metastasis by Emp1
Emp1 对髓母细胞瘤转移的调节
- 批准号:
9896856 - 财政年份:2016
- 资助金额:
$ 4.78万 - 项目类别:
Regulation of Medulloblastoma Metastasis by Emp1
Emp1 对髓母细胞瘤转移的调节
- 批准号:
9222061 - 财政年份:2016
- 资助金额:
$ 4.78万 - 项目类别:
Stem Cells, Progenitors, and the Origin of Medulloblastoma
干细胞、祖细胞和髓母细胞瘤的起源
- 批准号:
8244482 - 财政年份:2009
- 资助金额:
$ 4.78万 - 项目类别:
IMAGING OF PRE-NEOPLASTIC LESIONS IN A MOUSE MODEL OF MEDULLOBLASTOMA
髓母细胞瘤小鼠模型中肿瘤前病变的成像
- 批准号:
7956907 - 财政年份:2009
- 资助金额:
$ 4.78万 - 项目类别:
Stem Cells, Progenitors, and the Origin of Medulloblastoma
干细胞、祖细胞和髓母细胞瘤的起源
- 批准号:
7798066 - 财政年份:2009
- 资助金额:
$ 4.78万 - 项目类别:
Stem Cells, Progenitors, and the Origin of Medulloblastoma
干细胞、祖细胞和髓母细胞瘤的起源
- 批准号:
8063052 - 财政年份:2009
- 资助金额:
$ 4.78万 - 项目类别:
Stem Cells, Progenitors, and the Origin of Medulloblastoma
干细胞、祖细胞和髓母细胞瘤的起源
- 批准号:
8446152 - 财政年份:2009
- 资助金额:
$ 4.78万 - 项目类别:
相似海外基金
The role of ST6GAL2 and GM3 synthase dysregulation in the pathogenesis of Medulloblastoma. An in-vitro study.
ST6GAL2 和 GM3 合酶失调在髓母细胞瘤发病机制中的作用。
- 批准号:
24K19553 - 财政年份:2024
- 资助金额:
$ 4.78万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Analysis of Paediatric Medulloblastoma cellular heterogeneity using Single-cell transcriptomic profiling for improved therapeutic strategies
使用单细胞转录组分析分析儿科髓母细胞瘤细胞异质性以改进治疗策略
- 批准号:
2882274 - 财政年份:2023
- 资助金额:
$ 4.78万 - 项目类别:
Studentship
Prospective international phase-III study to improve neurocognitive outcomes in young children with low-risk medulloblastoma (YCMB-LR)
改善低危髓母细胞瘤幼儿神经认知结果的前瞻性国际 III 期研究 (YCMB-LR)
- 批准号:
10720110 - 财政年份:2023
- 资助金额:
$ 4.78万 - 项目类别:
Oncogenic mechanisms underlying GLI2-amplified medulloblastoma
GLI2扩增的髓母细胞瘤的致癌机制
- 批准号:
10561373 - 财政年份:2023
- 资助金额:
$ 4.78万 - 项目类别:
The Role of GABA Transaminase ABAT in Pediatric Brain Tumor Medulloblastoma Development and Spread
GABA 转氨酶 ABAT 在小儿脑肿瘤髓母细胞瘤发展和扩散中的作用
- 批准号:
10716956 - 财政年份:2023
- 资助金额:
$ 4.78万 - 项目类别:
Defining a targetable mechano-metastatic cascade to treat medulloblastoma metastasis
定义可靶向的机械转移级联来治疗髓母细胞瘤转移
- 批准号:
488101 - 财政年份:2023
- 资助金额:
$ 4.78万 - 项目类别:
Operating Grants
Investigation of ecDNA as a driver of intratumoral heterogeneity and treatment resistance in high-risk medulloblastoma
EcDNA 作为高危髓母细胞瘤瘤内异质性和治疗耐药性驱动因素的研究
- 批准号:
10709196 - 财政年份:2023
- 资助金额:
$ 4.78万 - 项目类别:
Developmental cellular origins of pediatric medulloblastoma
儿童髓母细胞瘤的发育细胞起源
- 批准号:
488211 - 财政年份:2023
- 资助金额:
$ 4.78万 - 项目类别:
Operating Grants
Enabling immunotherapy for high-risk Group 3 medulloblastoma via systems immunology
通过系统免疫学对高危 3 组髓母细胞瘤进行免疫治疗
- 批准号:
10714138 - 财政年份:2023
- 资助金额:
$ 4.78万 - 项目类别:
Naturally Targeted Exosomal TLR7/8 Agonist for Immunotherapy of Medulloblastoma
用于髓母细胞瘤免疫治疗的天然靶向外泌体 TLR7/8 激动剂
- 批准号:
10790660 - 财政年份:2023
- 资助金额:
$ 4.78万 - 项目类别: